Asthma Therapeutics Market Intelligence Report - Global Forecast to 2027

Asthma Therapeutics Market Intelligence Report - Global Forecast to 2027

The Global Asthma Therapeutics Market is projected to reach USD 36,871.67 million by 2027 from USD 20,313.30 million in 2021, at a CAGR 10.44% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Asthma Therapeutics Market size was estimated at USD 6,453.94 million in 2021 and expected to reach USD 7,016.93 million in 2022, at a CAGR 9.94% to reach USD 11,398.75 million by 2027.
• The Asia-Pacific Asthma Therapeutics Market size was estimated at USD 6,617.81 million in 2021 and expected to reach USD 7,395.87 million in 2022, at a CAGR 10.94% to reach USD 12,339.06 million by 2027.
• The Europe, Middle East & Africa Asthma Therapeutics Market size was estimated at USD 7,241.54 million in 2021 and expected to reach USD 7,979.36 million in 2022, at a CAGR 10.43% to reach USD 13,133.85 million by 2027.

Market Segmentation & Coverage:

The report on asthma therapeutics identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the asthma therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:

Drug Class:

• Anti-inflammatory
• Bronchodilators
• Combination Therapy

Product:

• Inhalers
  • Dry Powder Inhalers
  • Metered-dose Inhalers
  • Soft Mist Inhalers
• Nebulizers

Route of administration:

• Inhaled
• Oral

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Abbott Laboratories
• Amgen Inc.
• AstraZeneca PLC
• Becton, Dickinson and Company
• Biogen Inc.
• Boehringer Ingelheim GmbH
• Chiesi Farmaceutici S.p.A.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline PLC
• Kare Medical and Analytical Devices Ltd. Co.
• Koninklijke Philips N.V.
• Merck & Co. Inc.
• Merxin Ltd.
• Novartis AG
• Parekhplast India Limited
• Regeneron Pharmaceuticals, Inc.
• Sanofi S.A.
• Shenzhen Aeon Technology Co., Ltd.
• Softhale NV
• Sunovion Pharmaceuticals, Inc.
• Teva Pharmaceutical Industries Ltd.
• Trudell Medical Limited
• Viatris Inc.
• Wellinks, Inc.

Currency: USD

Base Year: 2021

Estimated Year: 2022

Forecast Year: 2027

Base Year Value: USD 20,313.30 million

Estimated Year Value: USD 22,392.17 million

Forecast Year Value: USD 36,871.67 million

CAGR (%): 10.44%.

Please Note: PDF & Excel + Online Access - 1 Year